Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-26T07:24:41.991Z Has data issue: false hasContentIssue false

Success of an Infection Control Program to Reduce the Spread of Carbapenem-Resistant Klebsiella pneumoniae

Published online by Cambridge University Press:  02 January 2015

Sandeep Kochar
Affiliation:
Infectious Diseases Division, State University of New York Downstate Medical Center, Brooklyn, New York
Timothy Sheard
Affiliation:
Infection Control Service, State University of New York Downstate Medical Center, Brooklyn, New York
Roopali Sharma
Affiliation:
Pharmacy Service, State University of New York Downstate Medical Center, Brooklyn, New York
Alan Hui
Affiliation:
Pharmacy Service, State University of New York Downstate Medical Center, Brooklyn, New York
Elaine Tolentino
Affiliation:
Microbiology Laboratory, State University of New York Downstate Medical Center, Brooklyn, New York
George Allen
Affiliation:
Infection Control Service, State University of New York Downstate Medical Center, Brooklyn, New York
David Landman*
Affiliation:
Infectious Diseases Division, State University of New York Downstate Medical Center, Brooklyn, New York
Simona Bratu
Affiliation:
Infectious Diseases Division, State University of New York Downstate Medical Center, Brooklyn, New York
Michael Augenbraun
Affiliation:
Infectious Diseases Division, State University of New York Downstate Medical Center, Brooklyn, New York
John Quale
Affiliation:
Infectious Diseases Division, State University of New York Downstate Medical Center, Brooklyn, New York
*
SUNY Downstate Medical Center, 450 Clarkson Ave., Box 77, Brooklyn, NY 11203) dlandman@downstate.edu)

Abstract

Objective.

To assess the effect of enhanced infection control measures with screening for gastrointestinal colonization on limiting the spread of carbapenem-resistant Klebsiella pneumoniae in a New York City hospital endemic for this pathogen.

Design.

Retrospective observational study with pre- and postinterventional phases.

Methods.

Beginning in 2006, a comprehensive infection control program was instituted in a 10-bed medical and surgical intensive care unit at a university-based medical center. In addition to being placed in contact isolation, all patients colonized or infected with carbapenem-resistant gram-negative bacilli, vancomycin-resistant Enterococcus, or methicillin-resistant Staphylococcus aureus were cohorted to one end of the unit. Improved decontamination of hands and environmental surfaces was encouraged. In addition, routine rectal surveillance cultures were screened for the presence of carbapenem-resistant pathogens. The number of patients per quarter with clinical cultures positive for carbapenem-resistant K. pneumoniae was compared during the approximately 2-year periods before and after the intervention.

Results.

The mean number ( ± SD) of new patients per 1,000 patient-days per quarter with cultures yielding carbapenem-resistant K. pneumoniae decreased from 9.7 ± 2.2 before the intervention to 3.7 ± 1.6 after the intervention (P< .001 ). There was no change in the mean number of patient-days or the mean number of patients per quarter with cultures yielding methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, or carbapenem-resistant Acinetobacter baumannii or Pseudomonas aeruginosa after the intervention. There was no association between antibiotic usage patterns and carbapenem-resistant K. pneumoniae.

Conclusions.

The comprehensive intervention that combined intensified infection control measures with routine rectal surveillance cultures was helpful in reducing the incidence of carbapenem-resistant K. pneumoniae in an intensive care unit where strains producing the carbapenemase KPC were endemic.

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Jacoby, GA, Munoz-Price, LS. The new β-lactamases. N Engl J Med 2005;352:380391.Google Scholar
2.Pitout, JD, Laupland, KB. Extended-spectrum 0-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8:159166.Google Scholar
3.Bratu, S, Landman, D, Haag, R, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 2005;165:14301435.CrossRefGoogle ScholarPubMed
4.Queenan, AM, Bush, K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007;20:440458.CrossRefGoogle ScholarPubMed
5.Marchaim, D, Navon-Venezia, S, Schwaber, MJ, Carmeli, Y. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbape-nemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother 2008;52:14131418.CrossRefGoogle Scholar
6.Patel, G, Huprikar, S, Factor, SH, Jenkins, SG, Calfee, DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:10991106.CrossRefGoogle ScholarPubMed
7.Landman, D, Bratu, S, Kochar, S, et al. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae in Brooklyn, NY. J Antimicrob Chemother 2007;60:7882.Google Scholar
8.Landman, D, Quale, JM, Mayorga, D, et al. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med 2002;162:15151520.Google Scholar
9.Calfee, D, Jenkins, SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008;29:966968.CrossRefGoogle ScholarPubMed
10.Tenover, FC, Kalsi, RK, Williams, PP, et al. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis 2006;12:12091213.Google Scholar
11.Bratu, S, Mooty, M, Nichani, S, et al. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 2005;49:30183020.Google Scholar
12.Landman, D, Salvani, JK, Bratu, S, Quale, J. Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures. J Clin Microbiol 2005;43:56395641.CrossRefGoogle ScholarPubMed
13.Woodford, N, Tierno, PM, Young, K, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York medical center. Antimicrob Agents Chemother 2004;48:47934799.CrossRefGoogle Scholar
14.Endimiani, A, Carias, LL, Hujer, AM, et al. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States. Antimicrob Agents Chemother 2008;52:26802682.CrossRefGoogle ScholarPubMed
15.Castanheira, M, Sader, HS, Deshpande, LM, Fritsche, TR, Jones, RN. Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-β-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 2008;52:570573.Google Scholar
16.Anderson, KF, Lonsway, DR, Rasheed, JK, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 2007;45:27232725.Google Scholar
17.Brooks, SE, Walczak, MA, Hameed, R. Are we doing enough to contain Acinetobacter infections? Infect Control Hosp Epidemiol 2000;21:304.Google Scholar